Procedimiento para la identificación y contabilización de Activos Intangibles de I+D.

Authors

  • Omarys Díaz Marante Centro de Inmunología Molecular
  • Rubén Gerardo Santos Lezcano
  • Kalet León Monzón Centro de Inmunología Molecular
  • Daineri Mosqueda Matos
  • Ileana Crespo Monzón

Abstract

Intangible assets are an essential component in value creation for biotechnology companies, where research and development (R&D) results represent a competitive advantage. However, their recognition and accounting treatment present limitations for identification, measurement, and recording. This research aims to design and implement a procedure for identifying and accounting for R&D intangible assets at the Center for Molecular Immunology (CIM). A mixed-methods approach was used, with a descriptive-analytical focus, based on an analysis of accounting standards (IAS 38 and NCC No. 8) and a study of R&D project management. As a result, a structured, step-by-step procedure is proposed that allows for the recognition, valuation, and recording of these assets. Validation of the procedure demonstrated a sustained increase in financing from amortization and strengthens the economic and financial management of innovation in the biotechnology sector.

Keywords: intangible assets, amortization, biotechnology.

Published

2026-10-10

How to Cite

Díaz Marante, O., Santos Lezcano, R. G., León Monzón, K., Mosqueda Matos, D., & Crespo Monzón, I. (2026). Procedimiento para la identificación y contabilización de Activos Intangibles de I+D . Industrial Engineering (Ingeniería Industrial), 47, 1–15. Retrieved from https://rii.cujae.edu.cu/index.php/revistaind/article/view/1370